Noninvasive prenatal testing in women undergoing in vitro fertilization with preimplantation genetic testing

Klimczak, A M, Seli, E, Scott, R T,
Curr Opin Obstet Gynecol. Jun. 2021 doi: 10.1097/GCO.0000000000000707


PURPOSE OF REVIEW: To discuss the utilization, performance, and interpretation of noninvasive prenatal testing (NIPT) results in women achieving pregnancy through in vitro fertilization (IVF) and preimplantation genetic testing for aneuploidy (PGT-A). RECENT FINDINGS: Although PGT-A is a highly accurate method for the selection of euploid embryos the possibility for error still exists. Many women pursue NIPT after conception via IVF with or without PGT-A, whereas some forgo prenatal screening all together. Recent evidence suggests that the prevalence of a positive NIPT following PGT-A is low, and the positive predictive value is altered in this population. SUMMARY: NIPT is a valuable prenatal screening tool that should be offered to pregnant women regardless of prior PGT. In women who conceive following IVF and PGT-A through the transfer of euploid embryos, positive test results should be interpreted with caution.